Hammond CL, Roztocil E, Phipps RP, Feldon SE, et al. Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor. PLoS One 2019;14:e0222779.
PMID: 31536596